Skip to the content
Investors
Careers
Darklogo darklogo light
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Dark
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Dark
  • About Us
  • Innovations
    • Therapeutics
    • Diagnostics
      • Point of Care Use Cases
      • Key Innovations
      • Communication
      • SeekIt™
  • Seekers
  • Partnering
  • News
  • Contact Us
  • Investors
  • Careers
Therapeutics

CRISPR Treatments for AI-Designed Synthetic Viruses: Rapid Programmable Countermeasures for Emerging and Engineered Viruses

Bridget Baldwin
December 5, 2025

Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
  • .pn-icon{fill:#fff;}
  • .tm-icon{fill:#fff;}
  • .vk-icon{fill:#fff;}
Previous post
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
Next post
Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats
Categories
Blog Corporate Diagnostics Featured Therapeutics
350 W 800 N, Suite 220
Salt Lake City, UT 84103
  • About Us
  • Seekers
  • Contact Us
  • Investors
  • Quality Policy
  • Innovations
  • Therapeutics
  • Diagnostics

    By submitting this form, you agree to our Terms of Service and Privacy Policy.

    Multiple Patents Pending | Copyright 2023 All Rights Reserved

    Terms of Service | Privacy Policy

    BioSeeker, PTAP, and SeekIt are investigational platforms currently in preclinical development. Not cleared or approved by the FDA or any other regulatory agency..

    Back to top Drag